kabutan

Solasia Pharma, The Current Fiscal Year's Net Income to Narrow

Wed Feb 12, 2025 4:00 pm JST Earnings

4597 Solasia Pharma K.K. 【IFRS】

Earnings Report

Solasia Pharma K.K. <4597> [TSE Growth] announced its financial results (based on IFRS) after the market closed on February 12th (16:00). The consolidated net loss for the fiscal year ending December 2024 expanded to a loss of 1.94 billion yen (compared to a loss of 1.11 billion yen in the previous period), but it is expected to shrink to loss of 0.65 billion yen for the fiscal year ending December 2025. This will mark the fifteenth consecutive term of losses.

In the most recent three-month period, from October to December (4Q), the consolidated net loss expanded to a loss of 1.07 billion yen (compared to a loss of 0.34 billion yen in the same period last year). However, the operating profit/loss margin improved from -2346.7% in the same period last year to -450.6%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2022 1,092 -2,470 -2,492 -2,548 -16.8 0 Feb 14, 2023 IFRS
Dec, 2023 617 -1,139 -1,135 -1,112 -6.6 0 Feb 14, 2024 IFRS
Dec, 2024 316 -1,951 -1,961 -1,941 -9.8 0 Feb 12, 2025 IFRS
YoY -48.8% -71.3% -72.8% -74.6% -47.6%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2024 Guidance 300 -1,050 -1,050 -1,050 -5.3 0 Jan 6, 2025 IFRS
Dec, 2024 Results 316 -1,951 -1,961 -1,941 -9.8 0 Feb 12, 2025 IFRS
Revision Rate +5.3% -85.8% -86.8% -84.9% -85.0%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2024 72 -611 -627 -611 -3.4 0 Aug 14, 2024 IFRS
Jan - Jun, 2025 Guidance ー ー ー ー － 0 Feb 12, 2025 IFRS
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 617 -1,139 -1,135 -1,112 -6.6 0 Feb 14, 2024 IFRS
Dec, 2024 316 -1,951 -1,961 -1,941 -9.8 0 Feb 12, 2025 IFRS
Dec, 2025 Guidance 1,300 -650 -650 -650 -2.5 0 Feb 12, 2025 IFRS
YoY +311.4% +66.7% +66.9% +66.5% +74.4%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2023 15 -352 -351 -344 -2.1 -2,346.7 Feb 14, 2024 IFRS
Jan - Mar, 2024 11 -307 -318 -310 -1.8 -2,790.9 May 15, 2024 IFRS
Apr - Jun, 2024 61 -304 -309 -301 -1.7 -498.4 Aug 14, 2024 IFRS
Jul - Sep, 2024 9 -281 -265 -260 -1.4 -3,122.2 Nov 13, 2024 IFRS
Oct - Dec, 2024 235 -1,059 -1,069 -1,070 -5.4 -450.6 Feb 12, 2025 IFRS
YoY +1,466.7% -200.9% -204.6% -211.0% -162.9%

Related Articles